Mendelspod Podcast
by Theral Timpson
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 18 chart positions in 18 markets.
By chart position
- 🇺🇸US · Natural Sciences#1365K to 30K
- 🇰🇷KR · Natural Sciences#20100K to 300K
- 🇮🇹IT · Natural Sciences#1061K to 10K
- 🇮🇳IN · Natural Sciences#1501K to 10K
- 🇸🇬SG · Natural Sciences#5100K to 300K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
78K to 246K🎙 Daily cadence·543 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
260K to 819K🇰🇷37%🇸🇬37%🇺🇸4%+15 more - Active Followers
Loyal subscribers who consistently listen
78K to 246K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 22 epsHost
Recent guests
Recent episodes
Agilent and Oxford Nanopore Discuss Bringing Long Reads to the Clinic with a Customer
Jul 9, 2026
29m 01s
Liquid Biopsy for the Tumor Microenvironment: with Vince Miller and Mirna Jarosz
Jun 30, 2026
4m 00s
Can Liquid Biopsy Transform Chronic Disease? Hamed Amini and Soheil Damangir of Hepta
Jun 25, 2026
4m 59s
The UAE’s Big Bet on Genomic Medicine with Mohamed Alameri and Albarah El-Khani
Jun 23, 2026
46m 26s
Ryan Flynn of Harvard on Non-Coding RNA
Jun 18, 2026
41m 11s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/9/26 | long read sequencingclinical genomics+3 | Dr. Parth ShahRita Shaknovich+1 | DartmouthAgilent+2 | — | long read sequencingacute leukemia+3 | — | 29m 01s | ||
| 6/30/26 | liquid biopsytumor microenvironment+3 | Dr. Vincent MillerDr. Mirna Jarosz | Foundation MedicineLiquidCell Dx+1 | — | liquid biopsytumor microenvironment+3 | — | 4m 00s | ||
| 6/25/26 | liquid biopsychronic disease+3 | Hamed AminiSoheil Damangir | Hepta | — | liquid biopsychronic disease+4 | — | 4m 59s | ||
| 6/23/26 | genomic medicineprecision medicine+3 | Mohamed AlameriAlbarah El-Khani | UAE Department of HealthM42 | UAEAbu Dhabi | genomicsEmirati Genome Program+3 | — | 46m 26s | ||
| 6/18/26 | non-coding RNAcell surface architecture+3 | Dr. Ryan Flynn | Harvard Medical SchoolBoston Children’s Hospital+2 | — | non-coding RNAglycoRNA+5 | — | 41m 11s | ||
| 6/11/26 | cellular behaviortranscriptome+3 | Gary Schroth | CellanomeIllumina | — | transcriptomicslive-cell imaging+5 | — | 32m 54s | ||
| 6/9/26 | breast cancerchemotherapy+4 | Phil FebboJohn Leite | VeracyteOPTIMA study | — | breast cancerchemotherapy avoidance+6 | — | 27m 06s | ||
| 5/29/26 | precision oncologycompanion diagnostics+4 | Rita ShaknovichKarina Kulangara | HerceptinPD-L1 IHC 22C3 PharmDx+1 | — | precision medicinecancer diagnostics+3 | — | 31m 31s | ||
| 5/28/26 | multi-omicsgenomics+5 | Dr. Eric Green | IlluminaNational Human Genome Research Institute | — | multi-omicsgenomics+5 | — | 44m 22s | ||
| 5/21/26 | proteomicsbiology+3 | Dr. Yan Zhang | Thermo Fisher Scientific | — | proteomicsThermo Fisher+3 | — | 4m 34s | ||
| 5/19/26 | epigeneticscancer detection+3 | Rob Osborne | BiomodalNature Communications Medicine | — | epigenetic marks5-methylcytosine+3 | — | 23m 19s | ||
| 5/15/26 | digital twinsmedical research+3 | Irina Babina | Concr | — | digital twinscancer research+3 | — | 4m 23s | ||
| 5/7/26 | genomicsDNA sequencing+3 | Shankar Balasubramanian | 6-base sequencingDNA polymerase+2 | — | Solexa6-base sequencing+5 | — | 37m 59s | ||
| 4/30/26 | biologyphysics+4 | Erdinc Sezgin | Karolinska InstituteBiophysical Society+1 | — | biophysicscell membrane+6 | — | 32m 55s | ||
| 4/28/26 | 6-base genomeepigenetics+3 | Peter Fromen | BiomodalIllumina+1 | — | 6-base genomeepigenetics+5 | — | 35m 29s | ||
| 4/14/26 | genomic medicinegenomic testing+5 | Damon Hostin | IlluminaCommonSpirit Health+1 | — | genomegenomic testing+7 | — | 39m 36s | ||
| 4/9/26 | spatial transcriptomicsgene expression+3 | Fei Chen | Takara Bio Trekker technologyThe Broad Institute | — | spatial transcriptomicsgene expression+5 | — | 31m 43s | ||
| 4/7/26 | peptidesdrug discovery+4 | Charlie JohannesTomi Sawyer | EPOC ScientificPeptide Drug Hunting Consortium+1 | — | peptidesdrug discovery+5 | — | 44m 06s | ||
| 4/2/26 | sequencing technologygenomics+4 | Mark Kokoris | SBX SequencerSequencing by Expansion (SBX)+5 | — | SBX SequencerSequencing by Expansion+8 | — | 35m 51s | ||
| 3/17/26 | agingbiology+3 | Steve Austad | University of Alabama at BirminghamMethuselah’s Zoo | — | aging researchlifespan+3 | — | 38m 22s | ||
| 3/10/26 | molecular residual diseaseoncology+3 | Chris HouriganGary Pestano | Fralin Biomedical Research Institute Cancer Research CenterVirginia Tech+1 | — | MRD testingoncology+6 | — | 33m 33s | ||
| 3/5/26 | breast cancerAI in medicine+3 | George Sledge | Oncotype DXCaris Life Sciences | — | breast cancerrecurrence+5 | — | 4m 06s |
Showing 22 of 22
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for Mendelspod Podcast
Peaked at #5 in SG, top 10 in 1 of 20 tracked markets, currently #5 in SG.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| SG | — | #5 | #5 | — |
| South Korea | — | #20 | #20 | — |
| CO | — | #30 | #30 | — |
| CH | — | #31 | #31 | — |
| South Africa | — | #45 | #45 | — |
| BE | — | #52 | #52 | — |
| VN | — | #62 | #62 | — |
| SG | — | #66 | #66 | — |
| GR | — | #69 | #69 | — |
| PT | — | #82 | #82 | — |
| AE | — | #83 | #83 | — |
| TW | — | #87 | #87 | — |
| AT | — | #88 | #88 | — |
| Italy | — | #106 | #106 | — |
| IL | — | #106 | #106 | — |
| Denmark | — | #131 | #131 | — |
| HK | — | #131 | #131 | — |
| United States | — | #136 | #136 | — |
| India | — | #150 | #150 | — |
| South Korea | — | #156 | #156 | — |
Chart Positions
20 placements across 18 markets.
Chart Positions
20 placements across 18 markets.